Literature DB >> 12435680

Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans.

Tanja Woyke1, Robert W Roberson, George R Pettit, Günther Winkelmann, Robin K Pettit.   

Abstract

The mechanism of action of the fungicidal peptide auristatin PHE was investigated in Cryptococcus neoformans. Since auristatin PHE causes budding arrest in C. neoformans (T. Woyke, G. R. Pettit, G. Winkelmann, and R. K. Pettit, Antimicrob. Agents Chemother. 45:3580-3584, 2001), microtubule integrity and nuclear localization in auristatin PHE-treated cells were examined. Iterative deconvolution in conjunction with an optimized C. neoformans microtubule immunolabeling procedure enabled detailed visualization of the microtubule cytoskeleton in auristatin PHE-treated C. neoformans. The effect of auristatin PHE on C. neoformans microtubule organization was compared with that of the tubulin-binding agent nocodazole. Both drugs produced complete disruption first of cytoplasmic and then of spindle microtubules in a time- and concentration-dependent manner. Sub-MICs of auristatin PHE caused complete microtubule disruption within 4.5 h, while 1.5 times the nocodazole MIC was required for the same effect. For both drugs, disruption of microtubules was accompanied by blockage of nuclear migration and of nuclear and cellular division, resulting in cells arrested in a uninucleate, large-budded stage. Nocodazole and the linear peptide auristatin PHE are remarkably different in structure and spectrum of activity, yet on the cellular level, they have similar effects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12435680      PMCID: PMC132747          DOI: 10.1128/AAC.46.12.3802-3808.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  40 in total

1.  Amino acid alterations in the benA (beta-tubulin) gene of Aspergillus nidulans that confer benomyl resistance.

Authors:  M K Jung; I B Wilder; B R Oakley
Journal:  Cell Motil Cytoskeleton       Date:  1992

Review 2.  Fungal infections in cancer patients.

Authors:  F Meunier
Journal:  Cancer Invest       Date:  1991       Impact factor: 2.176

Review 3.  Fluorescence microscopy in three dimensions.

Authors:  D A Agard; Y Hiraoka; P Shaw; J W Sedat
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

4.  Cross-resistance to polyene and azole drugs in Cryptococcus neoformans.

Authors:  T Joseph-Horne; D Hollomon; R S Loeffler; S L Kelly
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191

5.  Resistance to amphotericin B associated with defective sterol delta 8-->7 isomerase in a Cryptococcus neoformans strain from an AIDS patient.

Authors:  S L Kelly; D C Lamb; M Taylor; A J Corran; B C Baldwin; W G Powderly
Journal:  FEMS Microbiol Lett       Date:  1994-09-15       Impact factor: 2.742

6.  Site-directed mutagenesis of Saccharomyces cerevisiae beta-tubulin: interaction between residue 167 and benzimidazole compounds.

Authors:  J Li; S K Katiyar; T D Edlind
Journal:  FEBS Lett       Date:  1996-04-29       Impact factor: 4.124

Review 7.  Fungal infections in cancer patients: an escalating problem.

Authors:  G Samonis; D Bafaloukos
Journal:  In Vivo       Date:  1992 Mar-Apr       Impact factor: 2.155

8.  A single amino-acid substitution in the beta-tubulin gene of Neurospora confers both carbendazim resistance and diethofencarb sensitivity.

Authors:  M Fujimura; K Oeda; H Inoue; T Kato
Journal:  Curr Genet       Date:  1992-04       Impact factor: 3.886

9.  Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.

Authors:  J de Gans; P Portegies; G Tiessens; J K Eeftinck Schattenkerk; C J van Boxtel; R J van Ketel; J Stam
Journal:  AIDS       Date:  1992-02       Impact factor: 4.177

10.  Functions of microtubules in the Saccharomyces cerevisiae cell cycle.

Authors:  C W Jacobs; A E Adams; P J Szaniszlo; J R Pringle
Journal:  J Cell Biol       Date:  1988-10       Impact factor: 10.539

View more
  5 in total

1.  Antineoplastic agents. 590. X-ray crystal structure of dolastatin 16 and syntheses of the dolamethylleuine and dolaphenvaline units.

Authors:  George R Pettit; Thomas H Smith; Jun-Ping Xu; Delbert L Herald; Erik J Flahive; Collin R Anderson; Paul E Belcher; John C Knight
Journal:  J Nat Prod       Date:  2011-05-03       Impact factor: 4.050

Review 2.  The capsule of the fungal pathogen Cryptococcus neoformans.

Authors:  Oscar Zaragoza; Marcio L Rodrigues; Magdia De Jesus; Susana Frases; Ekaterina Dadachova; Arturo Casadevall
Journal:  Adv Appl Microbiol       Date:  2009       Impact factor: 5.086

3.  Differential gene expression in auristatin PHE-treated Cryptococcus neoformans.

Authors:  Tanja Woyke; Michael E Berens; Dominique B Hoelzinger; George R Pettit; Günther Winkelmann; Robin K Pettit
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

Review 4.  Aging as an emergent factor that contributes to phenotypic variation in Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Fungal Genet Biol       Date:  2014-10-13       Impact factor: 3.495

5.  Polo-like kinase Cdc5 regulates Spc72 recruitment to spindle pole body in the methylotrophic yeast Ogataea polymorpha.

Authors:  Hiromi Maekawa; Annett Neuner; Diana Rüthnick; Elmar Schiebel; Gislene Pereira; Yoshinobu Kaneko
Journal:  Elife       Date:  2017-08-30       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.